What is Dogwood Therapeutics's interest coverage?

Dogwood Therapeutics (DWTX) reported interest coverage of -89× in Q1 2026.

What does interest coverage mean?

Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.

Dogwood Therapeutics DWTX Interest coverage

Interest coverage at other companies

Vertex PharmaceuticalsVRTX

313.8×+310×

Collegium Pharmaceutical, Inc.COLL

2.4×+0.6×

Avanos MedicalAVNS

-9.1×-3.9×

PTH

Pelthos Therapeutics Inc.PTHS

-8.4×—

Other financials

Income statement

See full

Operating income-$5.1M-14.6%

Net income-$5.0M+54.4%

EPS (diluted)-$0.15+98.2%

Balance sheet

See full

Cash & equivalents$13.2M-24.6%

Total debt$144.9K-24.2%

Total equity$80.6M+1,038%

Total assets$95.2M-1.8%

Cash flow

See full

Operating cash flow-$4.6M+2.0%

Valuation

See full

Market cap$54.14M-57.6%

Enterprise value$41.06M-64.7%

Returns & leverage

See full

Return on equity-64.6%-29.8pp

Debt / equity0×0.0×

Current ratio5.9×-1.6×

Where this comes from

Calculated from Dogwood Therapeutics’s reported figures.

ebit/interest expense=-89×

Based on trailing twelve months.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dogwood Therapeutics's interest coverage?: Dogwood Therapeutics (DWTX) reported interest coverage of -89× in Q1 2026.
What does interest coverage mean?: Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.